In Brief: Breathe Right nasal strips
This article was originally published in The Tan Sheet
Executive Summary
Breathe Right nasal strips: Approved by FDA on June 7 for temporary relief of breathing problems caused by nasal septum deviation. Breathe Right was approved in November for reduction of snoring ("The Tan Sheet" Nov. 13, In Brief) and in March for temporary relief of nasal congestion; promotions will continue to focus on these two indications, marketer CNS, Inc. says. Breathe Right's first-quarter sales totaled $20.8 mil....
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning